Inside the research
Globe Life Inc.
GL Research profile · latest available data
Price overview
$167.04
▼ -0.28 (-0.2%)
| 52w hi | $186.02 |
|---|---|
| 52w lo | $129.57 |
| Vol | 594.80K |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.08
| Short | -0.25 |
|---|---|
| Medium | +0.21 |
| Long | +0.44 |
computed 2026-09-27
Key fundamentals
Globe Life Inc.
Financial Services · Insurance - Life
| Market cap | $12.84B |
|---|---|
| Enterprise value | $15.81B |
| Trailing P/E | 11.11x |
| Forward P/E | 10.11x |
| EV / EBITDA | 9.41x |
| P / S (ttm) | 2.07x |
| Profit margin | 19.6% |
| Return on equity | 20.9% |
| Revenue growth | +8.0% |
| Earnings growth | +19.7% |
| Debt / equity | 55.67 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.36 | |
| Sector | +0.02 | |
| Technical | +0.18 | |
| Earnings | +0.00 | |
| Sentiment | -0.55 |
macro × 1.00 · 2026-09-27
Business overview
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
Risk Metrics
| Beta vs SPX | 0.66 |
|---|---|
| Corr SPX | 0.44 |
| Annual vol | 23.9% |
| Annual ret | +25.5% |
| Sharpe | 1.07 |
| Max DD | -14.9% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $172.91 |
|---|---|
| High / Low | $199.00 / $147.00 |
| Median | $176.00 |
| Analysts | 11 |
| Strong Buy | 4 | |
|---|---|---|
| Buy | 4 | |
| Hold | 3 | |
| Sell | 0 | |
| Strong Sell | 0 |
Recent rating actions
| 2026-04-24 | Truist Securities | → Buy |
| 2026-04-10 | Wells Fargo | → Overweight |
| 2026-02-25 | Wells Fargo | → Overweight |
| 2026-02-18 | Evercore ISI Group | → In-Line |
| 2026-02-06 | Truist Securities | → Buy |
| 2026-02-05 | JP Morgan | → Overweight |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-07 | Officer / Director Change | read |
| 2026-07-22 | Earnings Release, Exhibits | read |
| 2026-06-29 | Material Agreement, Exhibits | read |
| 2026-05-04 | Officer / Director Change, Shareholder Vote | read |
| 2026-04-22 | Earnings Release, Exhibits | read |
| 2026-02-27 | Officer / Director Change | read |
| 2026-02-04 | Earnings Release, Exhibits | read |
| 2025-11-06 | Officer / Director Change, Exhibits | read |
| 2025-10-22 | Earnings Release, Exhibits | read |
| 2025-07-29 | Other Material Event, Exhibits | read |
| 2025-07-23 | Earnings Release, Exhibits | read |
| 2025-07-01 | Material Obligation | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-07 | MITCHELL ROBERT BRIAN | EVP, General Counsel and | Sell | 1.02K | $187.89K |
| 2026-08-07 | MITCHELL ROBERT BRIAN | EVP, General Counsel and | Sell | 10.53K | $1.94M |
| 2026-08-07 | MITCHELL ROBERT BRIAN | EVP, General Counsel and | Option exercise | 23.00K | $2.37M |
| 2026-08-07 | MITCHELL ROBERT BRIAN | EVP, General Counsel and | Sell | 11.45K | $2.09M |
| 2026-07-31 | Darden James Matthew | Co-Chairman & CEO | Sell | 49.60K | $9.05M |
| 2026-07-31 | Darden James Matthew | Co-Chairman & CEO | Sell | 400 | $73.34K |
| 2026-07-31 | Darden James Matthew | Co-Chairman & CEO | Option exercise | 50.00K | $4.92M |
| 2026-07-30 | Kalmbach Thomas Peter | EVP & CFO | Sell | 10.72K | $1.92M |
| 2026-07-30 | Kalmbach Thomas Peter | EVP & CFO | Option exercise | 11.00K | $1.33M |
| 2026-07-30 | Kalmbach Thomas Peter | EVP & CFO | Option exercise | 10.00K | $1.03M |
Flow & Concentration
| Insider 180d net | -$31.16M |
|---|---|
| Insider buys / sells | 0 / 23 |
| Insider bias | Sellers |
| 13F holders | 8 |
| Top-5 share | 96.6% |
| HHI | 3,383 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $667.44M | 3.74M |
| AQR Capital Management | $270.88M | 1.52M |
| Fidelity / FMR LLC | $226.37M | 1.27M |
| Capital Research / Capital World | $63.68M | 356.37K |
| Millennium Management | $33.02M | 184.77K |
| Citadel Advisors | $32.02M | 179.22K |
| Bridgewater Associates | $11.81M | 66.12K |
| T. Rowe Price Group | $49.49K | 276.99K |
As of 2026-06-30
Dividends
| Yield (TTM) | 0.52% |
|---|---|
| $ / share (TTM) | $0.87 |
| 5y CAGR | +7.3% |
Annual dividend per share
| 2021 | $0.78 |
|---|---|
| 2022 | $0.82 |
| 2023 | $0.88 |
| 2024 | $0.94 |
| 2025 | $1.05 |
| 2026 | $0.60 |
SEC Filings
The Long Run
FY 2009–2025 · 17 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $5.45B | +3.3% | |
| Gross profit | $1.26B | +4.7% | |
| Operating income | $1.23B | +4.7% | |
| Net income | $1.07B | +4.5% | |
| Cash from ops | $1.40B | +4.4% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $167.88 | $168.10 | $166.05 | $167.04 | 594.80K |
| Sep 24 | $169.03 | $170.45 | $167.25 | $167.32 | 765.30K |
| Sep 23 | $168.35 | $171.63 | $167.83 | $168.75 | 454.50K |
| Sep 22 | $173.21 | $174.37 | $168.82 | $169.43 | 389.80K |
| Sep 21 | $173.86 | $174.35 | $171.56 | $172.16 | 320.90K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →